908 Devices (MASS) FCF Margin Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1,716.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,811.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2,833.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 192.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 261.00 |
| 10 | 908 Devices | 314.43 Mn | 202.69 Mn | 6.88 Mn | 13,758.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,758.00 |
| Dec 31, 2025 | 2,459.00 |
| Sep 30, 2025 | 482.00 |
| Jun 30, 2025 | 6,281.00 |
| Mar 31, 2025 | 936.00 |
| Dec 31, 2024 | -119.00 |
| Sep 30, 2024 | -607.00 |
| Jun 30, 2024 | -4,030.00 |
| Mar 31, 2024 | -1,352.00 |
| Dec 31, 2023 | 3,343.00 |
| Sep 30, 2023 | 235.00 |
| Jun 30, 2023 | 2,656.00 |
| Mar 31, 2023 | -11,168.00 |
| Dec 31, 2022 | 935.00 |
| Sep 30, 2022 | -1,220.00 |
| Jun 30, 2022 | 132.00 |
| Mar 31, 2022 | 16,091.00 |
| Dec 31, 2021 | -9,933.00 |
| Sep 30, 2021 | -16,220.00 |
| Jun 30, 2021 | -6,584.00 |
| Mar 31, 2021 | -9,249.00 |